Trial Profile
Effects of tamoxifen vs raloxifene on proliferative activity in breast tissue in women who underwent subsequent surgical excision of benign breast nodules
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2014
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Tamoxifen (Primary)
- Indications Breast cancer
- Focus Biomarker; Pharmacodynamics
- 16 Jan 2014 New trial record
- 14 Dec 2013 Results presented at the 36th Annual San Antonio Breast Cancer Symposium.